Prevention of experimental pancreatitis by somatostatins.
Somatostatin is known to exert a beneficial cytoprotective effect in acute experimental pancreatitis, although it is ineffective regarding mortality in human pancreatitis. The somatostatin analog 008 was found to be more efficient in taurocholate-induced pancreatitis in rats and in ceruletid-induced pancreatitis.